Lrp4 is a receptor for Agrin and forms a complex with MuSK.

Lrp4 is a receptor for Agrin and forms a complex with MuSK.

Neuromuscular synapse formation requires a complex exchange of signals between motor neurons and skeletal muscle fibers, leading to the accumulation of postsynaptic proteins, including acetylcholine receptors in the muscle membrane and specialized release sites, or active zones in the presynaptic ne...

Полное описание

Библиографические подробности
Главные авторы:	Kim, N, Stiegler, A, Cameron, T, Hallock, P, Gomez, A, Huang, J, Hubbard, SR, Dustin, M, Burden, S
Формат:	Journal article
Язык:	English
Опубликовано:	2008

Схожие документы

A mutation causes MuSK reduced sensitivity to agrin and congenital myasthenia.
по: Asma Ben Ammar, и др.
Опубликовано: (2013-01-01)

Correction: A Mutation Causes MuSK Reduced Sensitivity to Agrin and Congenital Myasthenia
Опубликовано: (2013-01-01)

Correction: A Mutation Causes MuSK Reduced Sensitivity to Agrin and Congenital Myasthenia.
по: Asma Ben Ammar, и др.
Опубликовано: (2013-01-01)

MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters
по: Koneczny, I, и др.
Опубликовано: (2013)

MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters.
по: Koneczny, I, и др.
Опубликовано: (2013)

MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters.
по: Inga Koneczny, и др.
Опубликовано: (2013-01-01)

Agrin Influences Botulinum Neurotoxin A-Induced Nerve Sprouting via miR-144-agrin-MuSK Signaling
по: Lin Ma, и др.
Опубликовано: (2020-01-01)

The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis.
по: Koneczny, I, и др.
Опубликовано: (2014)

The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis
по: Koneczny, I, и др.
Опубликовано: (2014)

Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG.
по: Leite, M, и др.
Опубликовано: (2005)

Myasthenia gravis with MuSK antibodies
по: Farrugia, M, и др.
Опубликовано: (2005)

Potential mechanisms in MuSK-myasthenia gravis
по: Koneczny, I
Опубликовано: (2014)

MuSK-Myasthenia Gravis Unmasked by Hydroxychloroquine
по: Shalini Bhaskar, и др.
Опубликовано: (2022-01-01)

Synapse-specific Lrp4 mRNA enrichment requires Lrp4/MuSK signaling, muscle activity and Wnt non-canonical pathway
по: Hongyang Jing, и др.
Опубликовано: (2021-06-01)

Patient-specific therapeutic benefit of MuSK agonist antibody ARGX-119 in MuSK myasthenia gravis passive transfer models
по: Jamie L. Lim, и др.
Опубликовано: (2025-02-01)

Increasing MuSK Activity Delays Denervation and Improves Motor Function in ALS Mice
по: María J. Pérez-García, и др.
Опубликовано: (2012-09-01)

Infantile Onset Myasthenia Gravis with MuSK Antibodies
по: J Gordon Millichap
Опубликовано: (2006-08-01)

Studies of the MuSK system using molecular dynamics simulations
по: Buyan, A
Опубликовано: (2015)

The prevalence of MuSK antibody positive myasthenia gravis worldwide
по: Vincent, A, и др.
Опубликовано: (2006)

Preserving neuromuscular synapses in ALS by stimulating MuSK with a therapeutic agonist antibody
по: Sarah Cantor, и др.
Опубликовано: (2018-02-01)

Clinical aspects of MuSK antibody positive seronegative MG.
по: Sanders, D, и др.
Опубликовано: (2003)

Detection and characterization of MuSK antibodies in seronegative myasthenia gravis.
по: McConville, J, и др.
Опубликовано: (2004)

MuSK antibody-positive, seronegative myasthenia gravis in Korea.
по: Lee, J, и др.
Опубликовано: (2006)

Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis.
по: Shiraishi, H, и др.
Опубликовано: (2005)

MuSK Antibody Positive Myasthenia Gravis Mimicking as Myositis
по: Nilesh Wagh, и др.
Опубликовано: (2024-09-01)

MuSK-Associated Myasthenia Gravis: Clinical Features and Management
по: Carmelo Rodolico, и др.
Опубликовано: (2020-07-01)

Quantitative EMG of facial muscles in myasthenia patients with MuSK antibodies.
по: Farrugia, M, и др.
Опубликовано: (2007)

Dok-7/MuSK signaling and a congenital myasthenic syndrome.
по: Yamanashi, Y, и др.
Опубликовано: (2008)

Anti-MuSK antibodies in a case of ocular myasthenia gravis.
по: Bennett, D, и др.
Опубликовано: (2006)

Anti-MuSK antibody positive myasthenia gravis with childhood onset
по: Diana Epure, и др.
Опубликовано: (2016-06-01)

Progress in rituximab for anti⁃MuSK antibody-related myasthenia gravis
по: Ting LI, и др.
Опубликовано: (2020-01-01)

Clinical Characteristics of MuSK Antibody-positive Myasthenia Gravis in Taiwan
по: Yung-Chuan Huang, и др.
Опубликовано: (2008-07-01)

Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
по: Hoch, W, и др.
Опубликовано: (2001)

Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis.
по: Phillips, W, и др.
Опубликовано: (2015)

MuSK-antibody-positive myasthenia gravis in a South Asian population.
по: Chang, T, и др.
Опубликовано: (2009)

Anti-MuSK antibodies in seronegative myasthenia gravis: a cause of denervation
по: Newsom-Davis, J, и др.
Опубликовано: (2001)

Targeted treatment approaches and pathogenicity of antibody subclasses in MuSK-myasthenia gravis
по: Cao, M
Опубликовано: (2021)

Efgartigimod treatment in patients with anti-MuSK-positive myasthenia gravis in exacerbation
по: Fangyi Shi, и др.
Опубликовано: (2024-11-01)

Coexistence of anti-MuSK antibody-positive myasthenia gravis and rheumatoid arthritis
по: Amber Eker, и др.
Опубликовано: (2020-08-01)

Regional Features of MuSK Antibody-Positive Myasthenia Gravis in Northeast China
по: Zunwei Zhang, и др.
Опубликовано: (2020-10-01)